1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Pilot Grant Program (for various rare diseases including CADASIL, UGDH, ZC4H2, CDKL5 Deficiency Disorder, Adult Polyglucosan Body Disease, Bloom Syndrome) is sponsored by Orphan Disease Center - University of Pennsylvania. The Orphan Disease Center offers pilot grants for various rare diseases, supporting research related to specific conditions.
For example, the CDKL5 Pilot Grant Program provides funding for research related to CDKL5 Deficiency Disorder, and the APBD Pilot Grant Program supports research related to Adult Polyglucosan Body Disease. A Natural History Study grant is also offered to understand disease progression over time.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: All individuals holding a faculty-level appointment at an academic institution or a senior position at a non-profit institution or foundation are eligible. International applicants are often eligible. Confirm the full requirements in the official notice before applying.
The current listing shows varies by program: e.g., $150,000 for CDKL5; up to $50,000 or $100,000 for APBD; up to $50,000 for MDBR. One $90,000 grant for Natural History Study. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pilot Grant Program (for various rare diseases including CADASIL, UGDH, ZC4H2, CDKL5 Deficiency Disorder, Adult Polyglucosan Body Disease, Bloom Syndrome) is funded by Orphan Disease Center - University of Pennsylvania. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
The full ASPECT NOFO (DE-FOA-0003647) posted September 4, 2026, eleven days later than the Notice of Intent predicted. The real document splits $58 million across two topic areas with anticipated award counts of 0-7 and 0-3, a cost share that jumps from 20 percent to 50 percent mid-project, a mandatory five-page concept paper due October 9, and a university eligibility restriction that decides team structure before anyone writes a word.
Read articleThe Humana Foundation's first 2026 slate funded 13 nonprofits and five university research teams around senior and veteran emotional health, with awards from $150,000 to $3 million concentrated in Texas, Florida, and Kentucky. A second health equity slate is planned for fall 2026. Here is what the portfolio structure reveals about how this funder decides, and how aging-services and behavioral health organizations should position.
Read articleThe Hydrocarbons and Geothermal Energy Office's University Training and Research program funds coal, oil and gas, and geothermal R&D at U.S. colleges and universities — but every proposal must include a non-academic partner and must build training modules that outlive the award. The LOI deadline is October 1, 2026, with full applications 15 days later. Here is what that compressed window means and why the workforce framing changes what a competitive proposal looks like.
Read article